Novel pharmaceutically active flavilium compounds

The invention relates to a compound of formula (I) acceptable anion, R1 and R2 are independently of each other hydrogen, or an -OY group in which Y is hydrogen, an alpha -aminoacyl, or a C1-5 aminoalkyl residue, R3, R4 and R7 are independently of each other hydrogen, or a C1-5 alkyl residue R5 is hy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JANOS BALINT, GYORGY SULYOK, JOLAN KISS, FERENC D. TOTH, ILDIKO BORBELY
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JANOS BALINT
GYORGY SULYOK
JOLAN KISS
FERENC D. TOTH
ILDIKO BORBELY
description The invention relates to a compound of formula (I) acceptable anion, R1 and R2 are independently of each other hydrogen, or an -OY group in which Y is hydrogen, an alpha -aminoacyl, or a C1-5 aminoalkyl residue, R3, R4 and R7 are independently of each other hydrogen, or a C1-5 alkyl residue R5 is hydrogen, and alpha -aminoacyl, or a C1-5 alkyl residue, and R6 is hydrogen, OH-, or a C1-5 alkyl residue, and pharmaceutically acceptable salts and esters thereof; and to condensation processes for preparing them.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU660113BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU660113BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU660113BB23</originalsourceid><addsrcrecordid>eNrjZDD0yy9LzVEoyEgsyk1MTi0tyUxOzMmpVEhMLsksS1VIy0ksy8zJLM1VSM7PLcgvzUsp5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFQFPyUkviHUPNzAwMDY2dnIyMiVACAI6hLBU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Novel pharmaceutically active flavilium compounds</title><source>esp@cenet</source><creator>JANOS BALINT ; GYORGY SULYOK ; JOLAN KISS ; FERENC D. TOTH ; ILDIKO BORBELY</creator><creatorcontrib>JANOS BALINT ; GYORGY SULYOK ; JOLAN KISS ; FERENC D. TOTH ; ILDIKO BORBELY</creatorcontrib><description>The invention relates to a compound of formula (I) acceptable anion, R1 and R2 are independently of each other hydrogen, or an -OY group in which Y is hydrogen, an alpha -aminoacyl, or a C1-5 aminoalkyl residue, R3, R4 and R7 are independently of each other hydrogen, or a C1-5 alkyl residue R5 is hydrogen, and alpha -aminoacyl, or a C1-5 alkyl residue, and R6 is hydrogen, OH-, or a C1-5 alkyl residue, and pharmaceutically acceptable salts and esters thereof; and to condensation processes for preparing them.</description><edition>5</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>1995</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19950608&amp;DB=EPODOC&amp;CC=AU&amp;NR=660113B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19950608&amp;DB=EPODOC&amp;CC=AU&amp;NR=660113B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JANOS BALINT</creatorcontrib><creatorcontrib>GYORGY SULYOK</creatorcontrib><creatorcontrib>JOLAN KISS</creatorcontrib><creatorcontrib>FERENC D. TOTH</creatorcontrib><creatorcontrib>ILDIKO BORBELY</creatorcontrib><title>Novel pharmaceutically active flavilium compounds</title><description>The invention relates to a compound of formula (I) acceptable anion, R1 and R2 are independently of each other hydrogen, or an -OY group in which Y is hydrogen, an alpha -aminoacyl, or a C1-5 aminoalkyl residue, R3, R4 and R7 are independently of each other hydrogen, or a C1-5 alkyl residue R5 is hydrogen, and alpha -aminoacyl, or a C1-5 alkyl residue, and R6 is hydrogen, OH-, or a C1-5 alkyl residue, and pharmaceutically acceptable salts and esters thereof; and to condensation processes for preparing them.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1995</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDD0yy9LzVEoyEgsyk1MTi0tyUxOzMmpVEhMLsksS1VIy0ksy8zJLM1VSM7PLcgvzUsp5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFQFPyUkviHUPNzAwMDY2dnIyMiVACAI6hLBU</recordid><startdate>19950608</startdate><enddate>19950608</enddate><creator>JANOS BALINT</creator><creator>GYORGY SULYOK</creator><creator>JOLAN KISS</creator><creator>FERENC D. TOTH</creator><creator>ILDIKO BORBELY</creator><scope>EVB</scope></search><sort><creationdate>19950608</creationdate><title>Novel pharmaceutically active flavilium compounds</title><author>JANOS BALINT ; GYORGY SULYOK ; JOLAN KISS ; FERENC D. TOTH ; ILDIKO BORBELY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU660113BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1995</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>JANOS BALINT</creatorcontrib><creatorcontrib>GYORGY SULYOK</creatorcontrib><creatorcontrib>JOLAN KISS</creatorcontrib><creatorcontrib>FERENC D. TOTH</creatorcontrib><creatorcontrib>ILDIKO BORBELY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JANOS BALINT</au><au>GYORGY SULYOK</au><au>JOLAN KISS</au><au>FERENC D. TOTH</au><au>ILDIKO BORBELY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Novel pharmaceutically active flavilium compounds</title><date>1995-06-08</date><risdate>1995</risdate><abstract>The invention relates to a compound of formula (I) acceptable anion, R1 and R2 are independently of each other hydrogen, or an -OY group in which Y is hydrogen, an alpha -aminoacyl, or a C1-5 aminoalkyl residue, R3, R4 and R7 are independently of each other hydrogen, or a C1-5 alkyl residue R5 is hydrogen, and alpha -aminoacyl, or a C1-5 alkyl residue, and R6 is hydrogen, OH-, or a C1-5 alkyl residue, and pharmaceutically acceptable salts and esters thereof; and to condensation processes for preparing them.</abstract><edition>5</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU660113BB2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Novel pharmaceutically active flavilium compounds
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T10%3A46%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JANOS%20BALINT&rft.date=1995-06-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU660113BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true